Skip to main content

CORRECTION article

Front. Oncol., 28 April 2022
Sec. Gynecological Oncology
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.916310

Corrigendum: Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis

This article is a correction to:

  1. Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis

    1. Read original article
Jianying YiJianying Yi1Zhili Liu,,,Zhili Liu2,3,4,5Lu WangLu Wang6Xingxin ZhangXingxin Zhang7Lili PiLili Pi1Chunlei ZhouChunlei Zhou1Hong Mu*Hong Mu1*
  • 1Department of Clinical Laboratory, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
  • 2Department of Clinical Laboratory, The Third Central Hospital, Tianjin, China
  • 3Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases , Tianjin, China
  • 4Artificial Cell Engineering Technology Research Center, Tianjin, China
  • 5Tianjin Institute of Hepatobiliary Disease, Tianjin, China
  • 6Department of Gynecology and Obstetrics, Traditional Chinese Medicine Hospital of Xiaoyi City, Xiaoyi, China
  • 7Department of Clinical Laboratory, People’s Hospital of Xiaoyi City, Xiaoyi, China

A Corrigendum on:
Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis

By Yi J, Liu Z, Wang L, Zhang X, Pi L, Zhou C and Mu H (2022). Front. Oncol. 12:857375. doi: 10.3389/fonc.2022.857375

In the published article, there was an error in author information. Jianying Yi should be the sole first author, which means that Zhili Liu is not an equally contributing first author.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cervical cancer, lymph node metastasis, nomogram, overall survival, cancer-specific survival

Citation: Yi J, Liu Z, Wang L, Zhang X, Pi L, Zhou C and Mu H (2022) Corrigendum: Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis. Front. Oncol. 12:916310. doi: 10.3389/fonc.2022.916310

Received: 09 April 2022; Accepted: 11 April 2022;
Published: 28 April 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Yi, Liu, Wang, Zhang, Pi, Zhou and Mu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hong Mu, aG9uZ00wODEzQDE2My5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.